vialroom

#semaglutide 2026-04-09

Thursday38 messages9 participantstimes are UTC
Highlights from this day
  • declared_value — going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution 19:42
  • redefine_ren — SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial 20:29
  • declared_value — went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down 20:57
PP

my dose day drifted from friday to sunday, does that reset anything

PP

slower worked better

Cited study
Effects of Semaglutide on Chronic Kidney Disease in Type 2 Diabetes (FLOW)
New England Journal of Medicine · 2024
Renal outcomes. The one that changed a lot of nephrologists’ minds.
😂18

anyone gone from 1.7 straight to 2.4 or is that too big a jump

vials not pens here

whats the actual licensed ceiling, i keep seeing different numbers

how many weeks before you noticed anything at 10

VI

while im here is there a reason to hold at 1.7 rather than going to 2.4

VI

FLOW was the kidney outcomes trial and it gets quoted in here for things it didnt measure

PP

changed my mind on the four week rule, i think it depends entirely on how the current dose feels

👍1💀1🎉2
PM

does the licensed ceiling for weight differ from the diabetes one

*Janoshik not the other one

not the same trial

vial-sg-1177-front.png
900 × 1200 · 677 KB · not retained in the public archive

does moving my dose day by two days matter with a seven day half life

DV

i dont think the plateau is a dose problem most of the time, but i cant prove that

📉15
SH

$72 a month for compounded against what brand costs locally is why most people here use vials

🔥2💀4⚠️1
DV

update on the earlier thing i held at 2.5 for 6 months and it was the best decision i made

VB

Testing queue: 7 submissions open, 50 awaiting dispatch.

PM

compounded and brand felt the same to me at 2.5, which is one person and nothing more

DV

going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution

🤝10👀15
ST

the long half life flattens the trough more than people expect, i never felt a day seven dip, thats one data point

Cited study
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT)
New England Journal of Medicine · 2023
Hard cardiovascular endpoints in people with overweight or obesity and established disease.

im at 0.25 and stuck, did anyone break a plateau without going up

VB

New independent result logged — ERP, lot G-0641, purity 97.4% (PeptideMeter).

SH

if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule

🎉8💀3👍1
RR

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

🤝1❤️13🧊4
DV

went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down

❤️10🎉16
SH

restarted after 1 months off at a low dose and the nausea arrived exactly like the first time

PM

the appetite effect faded for me around 24 months and going up fixed it for a while

PM

went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step